|
Book Title: Treating and Preventing Adolescent Mental Health Disorders
> pp. [661]
UNDEFINED: AUTHORS
Treating and Preventing Adolescent Mental Health Disorders
Print ISBN 9780195173642, 2005
pp. [661]
opmental precursors of psychosis. Current Psychiatry Reports, 6, 168–175.
Jablensky, A. (1986). Epidemiology of schizophrenia: A European perspective. Schizophrenia Bulletin, 12, 52–73.
Jackson, H., McGorry, P., Henry, L., Edwards, J., Hulbert, C., Harrigan, S., et al. (2001). Cognitively oriented psychotherapy for early psychosis (COPE): A 1-year follow-up. British Journal of Clinical Psychology, 40, 57–70.
Jacobsen, L. K., Giedd, J. N., Castellanos, F. X., Vaituzis, A. C., Hamburger, S. D., Kumra, S., et al. (1998). Progressive reduction of temporal lobe structures in childhood-onset schizophrenia. American Journal of Psychiatry, 155, 678–685.
Jernigan, T. L., & Tallal, P. (1990). Late childhood changes in brain morphology observable with MRI. Developmental Medicine and Child Neurology, 32, 379–385.
Johannessen, J. L., McGlashan, T. H., Larsen, T. K., Horneland, M., Joa, I., Mardal, S., et al. (2001). Early detection strategies for untreated first-episode psychosis. Schizophrenia Research, 51, 39–46.
Jones, P. B. (1999). Longitudinal approaches to the search for the causes of schizophrenia: Past, present and future. In: W. F. Gattaz & H. Hafner (Eds.), Search for the causes of schizophrenia (Vol. 4, pp. 91–120). Berlin: Springer-Verlag.
Jones, P., & Done, D. (1997). From birth to onset: A developmental perspective of schizophrenia in two national birth cohorts. In M. Keshavan & R. Murray (Eds.), Neurodevelopment and adult psychopathology (pp. 119–136). Cambridge, UK: Cambridge University Press.
Jones, P. B., & Murray, R. M. (1991). The genetics of schizophrenia is the genetics of neurodevelopment. British Journal of Psychiatry, 158, 615–623.
Jones, P. B., & van Os, J. J. (2000). Commentary on Davidson, M., Reichenberg, A., Rabinowitz, J., Weiser, M., Kaplan, Z., & Mark, M. (1999). Behavioural and intellectual markers for schizophrenia in apparently healthy male adolescents. American Journal of Psychiatry, 156, 1328–1335; Evidence-Based Mental Health, 3, 89.
Kane, J. M. (1996). Treatment-resistant schizophrenic patients. Journal of Clinical Psychiatry, 57, 35–40.
Kane, J. M., Rifkin, A., Quitkin, F., Nayak, D., & Ramos-Lorenzi, J. (1982). Fluphenazine vs. placebo in patients with remitted, acute first-episode schizophrenia. Archives of General Psychiatry, 39, 70–73.
Kasai, K., Shenton, M. E., Salisbury, D. F., Hirayasu, Y., Lee, C. U., Ciszewski, A. A., et al. (2003a). Progressive decrease of left superior temporal gyrus gray matter volume in patients with first-episode schizophrenia. American Journal of Psychiatry, 160, 156–164.
Kasai, K., Shenton, M. E., Salisbury, D. F., Hirayasu, Y., Onitsuka, T., Spencer, M., et al. (2003b). Progressive decrease of left Heschl's gyrus and planum temporale gray matter volume in schizophrenia: A longitudinal MRI study of first-episode patients. Archives of General Psychiatry, 60, 766–775.
Kellner, R., Wilson, R. M., Muldawer, M. D., & Pathak, D. (1975). Anxiety in schizophrenia. The responses to chlordiazepoxide in an intensive design study. Archives of General Psychiatry, 32, 1246–1254.
Kemp, R., Hayward, P., Applewhaite, G., Everitt, B., & David, A. (1996). Compliance therapy in psychotic patients: Randomised controlled trial. British Medical Journal, 312, 345–349.
Kemp, R., Kirov, G., Everitt, B., Hayward, P., & David, A. (1998). Randomised controlled trial of compliance therapy: 18-month follow-up. British Journal of Psychiatry, 172, 413–419.
Kendler, K. S. (2000). Schizophrenia: Genetics. In B. J. Sadock & V. A. Sadock (Eds.), Comprehensive textbook of psychiatry (7th ed., pp. 1147–1159). New York: Lippincott, Williams, & Wilkins.
end p.661
|
|
|
|
